Sponsor pipeline

PRG Science & Technology Co., Ltd. clinical trial pipeline

Get alerts when PRG Science & Technology Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05847179 Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner… Werner Syndrome Recruiting 2026-10-05
Phase 1/2
NCT07131722 Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients… Neurofibromatosis Type II Not Yet Recruiting 2026-01-23
Phase 1
NCT07221240 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult… Amyotrophic Lateral Sclerosis Recruiting 2026-03-05

Disease areas by active trials

Get alerts when PRG Science & Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free